UC San Diego Health’s cancer program meets the highest standards for colorectal cancer care and is among a select group of medical centers accredited by the National Accreditation Program for Rectal Cancer. This accreditation reflects our dedication to continuously improving the prognosis and comfort of every patient with colorectal cancer.
Commission on Cancer's Quality of Care Measures
As part of our national accreditation status, UC San Diego Health's cancer program is also accredited by the Commission on Cancer (CoC), which collects standardized data from CoC-accredited health care settings to measure cancer care quality.
The data presented below is included in the CoC's quality-of-care measures for colon and rectal cancer, and are for 2017, the most recent year for which data is available. (Data is provided by the National Cancer Database.)
The purpose of the data is to compare the care of colorectal cancer patients at UC San Diego Health with other CoC-accredited cancer programs regionally and nationwide. UC San Diego's results compare favorably in all below measures. For more information about quality and safety measures, see
Quality Care.
| At least 12 regional lymph nodes removed and examined for resected colon cancer |
97.7% | 92.7% | 93.5% | 94.7% | 93.2% |
| Chemo and radiation therapy, administered or recommended for resected rectal cancers |
100.0% | 89.2% | 87.9% | 84.7% | 87.8% |